Skip to main content

Table 2 Clinical and pathological features of the patients who experienced recurrence

From: Assessment of the prognostic role of neutrophil-to-lymphocyte ratio following complete resection of thymoma

Pt #

Age

Sex

MG

NLR

NT

WHO

Masaoka

TNM

AT

DFS

Site

OS

LFU

14

36

M

yes

2.16

no

B3

III

IIIA

yes

27

LR

31

AL

15

63

M

no

5.85

no

B3

III

IIIB

yes

16

LR

47

AL

32

50

M

no

1.68

yes

B2

IV

IIIA

yes

48

LR

61

AL

39

36

M

no

2.27

no

B2

III

I

yes

48

LR

99

AL

50

72

M

no

2.46

no

B3

II

I

yes

24

LR

75

D

66

52

F

no

2.61

yes

B2

III

IIIA

yes

57

LR

59

AL

  1. Legend: NT Neoadjuvant therapy, AT Adjuvant therapy, LR Loco-regional recurrence, LFU Status at the time of the last follow up, AL Alive, D Deceased